SCHEMBL6663823

SCHEMBL6663823

O=CNc1ccc(Nc2ncnc3ccc([N+](=O)[O-])cc23)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 1/20 0.74
EGFR P00533 8/20 0.73
ALDH1A1 P00352 4/20 0.67
MAPT P10636 4/20 0.67
HTT P42858 4/20 0.67
L3MBTL1 Q9Y468 1/20 0.67
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
EIF2AK2 P19525 1/20 0.62
ABCG2 Q9UNQ0 2/20 0.58
PIK3CA P42336 1/20 0.55
PIK3CG P48736 1/20 0.55
KIT P10721 1/20 0.55
GAA P10253 1/20 0.54
NCOA1 Q15788 1/20 0.54
NCOA3 Q9Y6Q9 1/20 0.54
TNF P01375 1/20 0.52
POLB P06746 1/20 0.52
CRHBP P24387 1/20 0.52
MAPK1 P28482 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4587672 0.86 ALK (0.79) ALKEGFRALDH1A1MAPTHTT
SCHEMBL3244626 0.85 ALK (0.77) ALKEGFRALDH1A1MAPTHTT
SCHEMBL1192454 0.85 EGFR (1.00) ALKEGFRALDH1A1MAPTHTT
SCHEMBL5532975 0.82 ALK (0.76) ALKEGFRALDH1A1MAPTHTT
SCHEMBL6666471 0.81 EGFR (0.68) EGFRKIT
SCHEMBL1387227 0.80 EGFR (0.80) ALKEGFRALDH1A1MAPTHTT
SCHEMBL6665852 0.80 ALK (0.70) ALKEGFRALDH1A1MAPTHTT
SCHEMBL29199908 0.80 ALK (0.70) ALKEGFRALDH1A1MAPTHTT
SCHEMBL30827902 0.80 ALK (0.70) ALKEGFRALDH1A1MAPTHTT
SCHEMBL6668474 0.80 HTT (0.68) ALKEGFRALDH1A1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004013091-A2 4-ANILIDO SUBSTITUTED QUINAZOLINES AND USE THEREOF AS INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-02-12 WO claimed
WO-2004013091-A2 4-ANILIDO SUBSTITUTED QUINAZOLINES AND USE THEREOF AS INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-02-12 WO disclosed